157
Views
45
CrossRef citations to date
0
Altmetric
Review Article

Cromolyn Sodium: Fitting an Old Friend into Current Asthma Treatment

, M.D. & , M.D.
Pages 79-89 | Published online: 26 Aug 2009

References

  • Berman B A, Fenton M M, Girsh L S, Haddad Z H, Sellars W A, Strem E L, Thompson H C, Wall L E. Cromolyn sodium in the treatment ofchildren with severe, perennial asthma. Pediatrics 1975; 55(5):621–629. [PUBMED], [INFOTRIEVE]
  • Bernstein I L, Johnson C L. Therapy with cromolyn sodium. Ann Intern Med 1978; 89(2):228–233. [PUBMED], [INFOTRIEVE]
  • Howell J BL, Altounyan R E. A double-blind trial of disodium cromoglycate in the treatment of allergic bronchial asthma. Lancet 1967; 2(7515):539–542. [PUBMED], [INFOTRIEVE], [CSA]
  • Northern General Hospital, Brompton Hospital, and Medical Research Council Collaborative Trial. Sodium cromoglycate in chronic asthma. Br Med J 1976; 1:361–364.
  • Furukawa C T, Shapiro G G, Bierman C W, Kraemer M J, Ward D J, Pierson W E. A double-blind study comparing the effectiveness of cromolyn sodium and sustained-release theophylline in childhood asthma. Pediatrics 1984; 74(4):453–459. [PUBMED], [INFOTRIEVE]
  • Cox J S. Disodium cromoglycate (FPL 670) (“Intal”): a specific inhibitor of reaginic antibody-antigen mechanisms. Nature 1967; 216(122):1328–1329. [PUBMED], [INFOTRIEVE]
  • Walker S R, Evans M E, Richards A J, Paterson J W. The fate of 14C disodium cromglycate in man. J Pharm Pharmacol 1972; 24:525–531. [PUBMED], [INFOTRIEVE]
  • Moss G F, Jones K M, Ritchie J T, Cox J S. Plasma levels and urinary excretion of disodium cromglycate after inhalation by human volunteers. Toxicol Appl Pharmacol 1971; 20:147–156. [PUBMED], [INFOTRIEVE]
  • Diaz P, Galleguillos F R, Gonzalez M C, Pantin C F, Kay A B. Bronchoalveolar lavage in asthma: the effect of disodium cromoglycate (cromolyn) on leukocyte counts, immunoglobulins, and complement. J Allergy Clin Immunol 1984; 74(1):41–48. [PUBMED], [INFOTRIEVE], [CSA]
  • Kay A B, Walsh G M, Moqbel R, MacDonald A J, Nagakura T, Carroll M P, Richerson H B. Disodium cromoglycate inhibits activation of human inflammatory cells in vitro. J Allergy Clin Immunol 1987; 80(1):1–8. [PUBMED], [INFOTRIEVE], [CSA]
  • Tsicopoulos A, Lassalle P, Joseph M, Tonnel A B, Thorel T, Dessaint J P, Capron A. Effect of disodium cromoglycate on inflammatory cells bearing the Fc epsilon receptor (Fc epsilon RII). Int J Immunopharmacol 1988; 10(3):227–236. [PUBMED], [INFOTRIEVE], [CSA]
  • Rand T H, Lopez A F, Gamble J R, Vadas M A. Nedocromil sodium and cromolyn (sodium cromoglycate) selectively inhibit antibody cytotoxicity. Int Arch Allergy Appl Immunol 1988; 87(2):151–158. [PUBMED], [INFOTRIEVE], [CSA]
  • Kimata H, Yoshida A, Ishioka C, Mikawa H. Disodium cromoglycate (DSDG) selectively inhibits IgE production and enhances IgG4 production by human B cells in vitro. Clin Exp Immunol 1991; 84(3):395–399. [PUBMED], [INFOTRIEVE]
  • Loh R K, Jabara H H, Geha R S. Disodium cromoblycate inhibits S mu → S epsilon deletional switch recombination and IgE synthesis in human B cells. J Exp Med 1994; 180(2):663–671. [PUBMED], [INFOTRIEVE]
  • Schmutzler W, Bolsmann K, Zwadio-Klarwavassar G. Comparison of histamine release from human blood monocytes, lymphocytes, adenoidal and skin mast cells. Int Arch Allergy Immunol 1995; 107(1–3):194–196. [PUBMED], [INFOTRIEVE], [CSA]
  • Alton E W, Norris A A. Chloride transport and the actions of nedocromil sodium and cromolyn sodium in asthma. J Allergy Clin Immunol. 1996; 98(5 Pt 2):S105–S106.
  • Hoshino M, Nakamura Y. The effect of inhaled sodium cromoglycate on cellular infiltration into the bronchial mucosa and the expression of adhesion molecules in asthmatics. Eur Respir J 1997; 10(4):858–865. [PUBMED], [INFOTRIEVE]
  • Jahnová E, Horváthová M, Gazdik F. Expression of adhesion molecules and effect of disodium cromoglycate treatment in asthmatics. Physiol Res 1998; 47(6):439–443. [CSA]
  • Sheard P, Blair A MJN. Disodium cromoglycate: activity in three in vitro models of the immediate hypersensitivity reaction in lung. Int Arch Allergy Appl Immunol 1970; 38(2):217–224. [PUBMED], [INFOTRIEVE]
  • Flint K C, Leung K B, Hudspith B N, Pearce F L, Brostoff J, Jhonson N M. The function and properties of human lung mast cells. Respiration 1986; 50:31–41. [PUBMED], [INFOTRIEVE]
  • Leung K B, Flint K C, Brostoff J, Hudspith B N, Johnson N M, Lau H Y, Liu W L, Pearce F L. Effects of sodium cromoglycate and nedocromil sodium on histamine secretion from human lung mast cells. Thorax 1988; 43(10):756–761. [PUBMED], [INFOTRIEVE]
  • Nagy L. The effect of disodium-chromoglycate on human serum neutrophil-chemotactic activity in antigen-induced bronchospasm. Allergy Immunol (Leipz) 1981; 27(1):48–52.
  • Skedinger M C, Augustine N H, Morris E Z, Nielson D W, Zimmerman G A, Hill H R. Effect of disodium cromoglycate on neutrophil movement and intracellular calcium mobilization. J Allergy Clin Immunul 1987; 80(4):573–577.
  • Moscato G, Rampulla C, Dellabianca A, Zanotti E, Candura S. Effect of salbutamol and inhaled sodium cromoglycate on the airway and neturophil chemotactic activity in ‘fog’ induced bronchoconstriction. J Allergy Clin Immunol 1988; 82(3 Pt 1):382–388. [PUBMED], [INFOTRIEVE]
  • Bruijnzeel P L, Warringa R A, Kok P T. Inhibition of platelet-activating factor- and zymosan-activated serum- induced chemotaxis of human neutrophils by nedocromil sodium, BN 52021 and sodium cromoglycate. Br J Pharmacol 1989; 97(4):1251–1257. [PUBMED], [INFOTRIEVE], [CSA]
  • Kilpatrick L E, Jakabovics E, McCawley L J, Kane L H, Korchak H M. Cromolyn inhibits assembly of the NADPH oxidase and superoxide anion generation by human neutrophils. J Immunol 1995; 154(7):3429–3436. [PUBMED], [INFOTRIEVE]
  • Lindqvist A, Karjalainen E M, Laitinen L A, Kava T, Altraja A, Pulkkinen M, Halme M, Laitinen A. Salmeterol resolves airway obstruction but does not possess anti-eosinophil efficacy in newly diagnosed asthma: a randomized, double-blind, parallel group biopsy study comparing the effects of salmeterol, fluticasone priopionate, and disodium cromoglycate. J Allergy Clin Immunol 2002; 112(1):23–28. [CSA]
  • Horvathova,, et al. 1998.
  • Lavin N, Rachelefsky G S, Kaplan S A. An action of disodium cromoglycate: inhibition of cyclic 3′,5′-AMP phosphodiesterase. J Allergy Clin Immunol 1976; 57(1):80–88. [PUBMED], [INFOTRIEVE]
  • Ichikawa K, Baba M, Yoshizawa I, Noma T. Study on the effect of disodium cromoglycate (DSCG) on antigen induced IL_2 responsiveness. Arerugi 1989; 38(10):1163–1168. [PUBMED], [INFOTRIEVE]
  • Holen E, Elsayed S. The effect of disodium cromoglycate (DSCG) on in vitro proliferation of CD4+, CD8+, and CD19+ cell populations derived from allergic and healthy donors. Allergy 1995; 50(3):249–256. [PUBMED], [INFOTRIEVE], [CSA]
  • Bansai S K, Jha A, Jaiswal A S, Chhabra S K. Increased levels of protein kinase C in lymphosytes in asthma: possible mechanisms of regulation. Eur Respir J 1997; 10(2):308–313.
  • Oh J W, Lee H B, Chung Y H, Choi Y. The effect of disodium cromoglycate, budesonide, and cyclosporine A on interleukin-4, interleukin-5, and interleukin-13 secretions in Der pI-stimulated T cells from house dust mite-sensitive atopic and nonatopic individuals. Allergy Asthma Proc 2002; 23(2):109–115. [PUBMED], [INFOTRIEVE], [CSA]
  • Cockcroft D W, Murdock K Y. Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. J Allergy Clin Immunol 1987; 79(5):734–740. [PUBMED], [INFOTRIEVE]
  • Mattoli S, Foresi A, Corbo G M, Velente S, Ciappi G. Effects of two doses of cromolyn on allergen-induced late asthmatic responses and increased responsiveness. J Allergy Clin Immunol 1987; 79(5):741–754.
  • Pelikan Z, Pelikan-Filipek M, Schoemaker M C, Berger M P. Effects of disodium cromoglycate and beclomethasone dipropionate on the asthmatic response to allergen challenge I. Immediate response (IAR). Ann Allergy 1988; 60(3):211–216. [PUBMED], [INFOTRIEVE], [CSA]
  • Pelikan Z, Pelikan-Filipek M, Schoemaker M C, Berger M P. Effects of disodium cromoglycate and beclomethasone dipropionate on the asthmatic response to allergen challenge II. Late response (IAR). Ann Allergy 1988; 60(3):217–225. [PUBMED], [INFOTRIEVE], [CSA]
  • Heaton R W, Henderson A F, Gray B J, Costello J F. The bronchial response to cold air challenge: evidence for different mechanisms in normal and asthmatic subject. Thorax 1983; 38(7):506–511. [PUBMED], [INFOTRIEVE]
  • Juniper E F, Latimer K M, Morris M M, Roberts R S, Hargreave F E. Airway responses to hyperventilation of cold dry air: duration ofprotection by cromolyn sodium. J Allergy Clin Immunol 1986; 78(3 Pt 1):387–391. [PUBMED], [INFOTRIEVE]
  • Bascom R, Bleecker E R. Bronchoconstriction induced by distilled water. Sensitivity in asthmatics and relationship to exercise-induced bronchospasm. Am Rev Respir Dis 1986; 134(2):248–253. [PUBMED], [INFOTRIEVE]
  • Black J L, Smith C M, Anderson S D. Cromolyn sodium inhibits the increased responsivenenss to methacholine that follows ultrasonically nebulized water challenge in patients with asthma. J Allergy Clin Immunol 1987; 80(1):39–44. [PUBMED], [INFOTRIEVE], [CSA]
  • delBufalo D, Fasano L, Patalano F, Gunella G. Inhibition of fog-induced bronchoconstriction by nedocromil sodium and sodium cromoglycate in intrinsic asthma: a double-blind, placebo-controlled study. Respiration 1989; 55(3):181–184.
  • Tranfa C M, Vatrella A, Parrella R, Bariffi F. Effect of ipratropium bromide and/or sodium cromoglycate pretreatment on water-induced bronchoconstriction in asthma. Eur Respir J 1995; 8(4):600–604. [PUBMED], [INFOTRIEVE]
  • Siffredi M, Mastropasqua B, Pelucchi A, Chiesa M, Marazzini L, Foresi A. Effect of inhaled furosemide and cromolyn on bronchoconstriction induced by ultrasonically nebulized distilled water in asthmatic subjects. Ann Allergy Asthma Immunol 1997; 78(2):238–243. [PUBMED], [INFOTRIEVE], [CSA]
  • Kivity S, Yarchovsky J, Greif J, Topilsky M. Combined effect of inhaled verapamil and sodium cromoglycate on the airway response to hypertonic saline. Ann Allergy 1990; 64(2 Pt 1):163–165. [PUBMED], [INFOTRIEVE], [CSA]
  • Anderson S D, du Toit J I, Rodwell L T, Jenkins C R. Acute effect of sodium cromoglycate on airway narrowing induced by 4.5% saline aerosol. Outcome before and during treatment with aerosol corticosteroids in patients with asthma. Chest 1994; 105(3):673–680. [PUBMED], [INFOTRIEVE]
  • Crimi N, Palermo F, Vancheri C, Oliveri R, Distefano S M, Polosa R, Mistretta A. Effect of sodium cromoglycate and nifedipine on adenosine-induced bronchoconstriction. Respiration 1988; 53(2):74–80. [PUBMED], [INFOTRIEVE]
  • Phillips G D, Scott V L, Richards R, Holgate S T. Effect of nedocromil sodium and sodium cromoglycate against bronchoconstriction induced by inhaled adenosine 5′-monophosphate. Eur Respir J 1989; 2(3):210–217. [PUBMED], [INFOTRIEVE]
  • Sheppard D, Nadel J A, Boushey H A. Inhibition of sulfur dioxide-induced bronchoconstriction by disodium cromoglycate in asthmatic subjects. Am Rev Respir Dis 1981; 124(3):257–259. [PUBMED], [INFOTRIEVE]
  • Tan W C, Cripps E, Doublas N, Sudlow M F. Protective effect of drugs on bronchoconstriction induced by sulphur dioxide. Thorax 1982; 37(9):671–675. [PUBMED], [INFOTRIEVE]
  • Dixon C M, Ind P W. Inhaled sodium metabisuphite induced bronchoconstriction: inhibition by nedocromil sodium and sodium cromoglycate. Br J Clin Pharmacol 1990; 30(3):371–376. [PUBMED], [INFOTRIEVE]
  • Fabbri L M, Mapp C E, Hendrick D J. Effect of cromolyn on carbachol-induced bronchoconstriction. Ann Allergy 1983; 50(3):195–198. [PUBMED], [INFOTRIEVE]
  • Barbato A, Pisetta F, Mesirca P, Ragusa A, Zacchello F. Sodium cromoglycate and carbachol-induced bronchoprovocation in asthmatic children. Pediatr Pulmonol 1987; 3(3):161–165. [PUBMED], [INFOTRIEVE]
  • Dixon C M, Barnes P J. Bradykinin-induced bronchoconstriction: inhibition by nedocromil sodium and sodium cromoglycate. Br J Clin Pharmacol 1989; 27(6):831–836. [PUBMED], [INFOTRIEVE]
  • Crimi N, Palermo F, Oliveri R, Vancheri C, Palermo B, Polosa R, Mistretta A. Bronchospasm induced by inhalation of substance P: effect of sodium cromoglycate. Respiration 1988; 54:95–99. [PUBMED], [INFOTRIEVE]
  • Miszkiel K A, Beasley R, Holgate S T. The influence of ipratropium bromide and sodium cromoglycate on benzalkonium chloride-induced bronchoconstriction in asthma. Br J Clin Pharmacol 1988; 26(3):295–301. [PUBMED], [INFOTRIEVE]
  • Michel O, Ginanni R, Sergysels R. Protective effect of sodium cromoglycate on lipopolysachharide-induced bronchial obstruction in asthmatics. Int Arch Allergy Immunol 1995; 108(3):298–302. [PUBMED], [INFOTRIEVE], [CSA]
  • Altounyan R E. Inhibition of experimental asthma by a new compound—disodium cromoglycate “Intal”. Acta Allergol 1967; 24:487–488.
  • Cox J S. Disodium cromoglycate: mode of action and its possible relevance to the clinical use of the drug. Br J Dis Chest 1971; 65(4):189–204. [PUBMED], [INFOTRIEVE]
  • Orr T SC, Gwilliam J, Cox J S. Studies on passive cutaneous anaphylaxis in the rat with disodium cromoglycate. II. A comparison of the rat anti-dnp 7S 2 and rat reagin induced cutaneous reaction. Immunology 1971; 21(3):405–417. [PUBMED], [INFOTRIEVE]
  • Hoshino M, Nakamura Y, Sim J J, Tomioka H. A comparative study of the effects of ketotifen, disodium cromoglycate, and beclomethasone dipropionate on bronchial mucosa and asthma symptoms in patients with atopic asthma. Respir Med 1998; 92(7):942–950. [PUBMED], [INFOTRIEVE], [CSA]
  • Heiman A S, Newton L. Effect of hydrocortisone and disodium cromoglycate on mast cell-mediator release induced by substance P. Pharmacology 1995; 50(4):218–228. [PUBMED], [INFOTRIEVE], [CSA]
  • Yamawaki I, Tamaoki J, Takeda Y, Nagai A. Inhaled cromoglycate reduces airway neurogenic inflammation via tachykinin antagonism. Res Commun Molec Pathol Pharmacol 1997; 98(3):265–272. [CSA]
  • Anderson S D, Rodwell L T, Daviskas E, Spring J F, du Toit J. The protective effect of nedocromil sodium and other drugs on airway narrowing provoked by hyperosmolar stimuli: a role for the airway epithelium?. J Allergy Clin Immunol 1996; 98(5 Pt 2):S124–S134. [PUBMED], [INFOTRIEVE], [CSA]
  • Bernstein I L, Siegel S C, Brandon M L, Brown E B, Evans R R, Feinberg A R, Friedlaender S, Krunholz R A, Hadley R A, Handelman N T, Thurston D, Yamate M. A controlled study of cromolyn sodium sponsored by the Drug Committee of the American Academy of Allergy. J Allergy Clin Immunol 1972; 50(4):235–245. [PUBMED], [INFOTRIEVE]
  • Lal S, Malhotra S M, Gribben M D. Comparison of sodium cromoglycate pressurized aerosol and powder in the treatment of asthma. Clin Allergy 1982; 12(2):197–201. [PUBMED], [INFOTRIEVE]
  • Blumenthal M N, Selcow J, Spector S, Zeiger R S, Mellon M. A multicenter evaluation of the clinical benefits of cromolyn sodium aerosol by metered-dose inhaler in the treatment of asthma. J Allergy Clin Immunol 1988; 81(4):681–687. [PUBMED], [INFOTRIEVE]
  • Petty T L, Rollins D R, Christopher K, Good J T, Oakley R. Cromolyn sodium is effective in adult chronic asthmatics. Am Rev Respir Dis 1989; 139(3):694–701. [PUBMED], [INFOTRIEVE]
  • Glass J, Archer L N, Adams W, Simpson H. Nebulised cromoglycate, theophylline, and placebo in preschool asthmatic children. Arch Dis Child 1981; 56(8):648–651. [PUBMED], [INFOTRIEVE]
  • Prenner B M. Safety, efficacy and bronchodilator-sparing effects of nebulized cromolyn sodium solution in the treatment of asthma in children. Ann Allergy 1982; 49(4):186–190. [PUBMED], [INFOTRIEVE]
  • Newth C J, Newth C V, Turner J A. Comparison of nebulised sodium cromoglycate and oral theophylline in controlling symptoms of chronic asthma in pre-school children: a double-blind study. Aust N Z J Med 1982; 12(3):232–238. [PUBMED], [INFOTRIEVE]
  • Stoloff S W. The changing role of theophylline in pediatric asthma. Am Family Physician 1994; 49(4):839–844.
  • Ross R N, Morris M, Sakowitz S R, Berman B A. Cost-effectiveness of including cromolyn sodium in the treatment program for asthma: a retrospective, record-based study. Clin Ther 1988; 10(2):188–203. [PUBMED], [INFOTRIEVE]
  • Donahue J G, Weiss S T, Livingston J M, Goetsch M A, Greineder D K, Plattt R. Inhaled steroids and the risk of hospitalization for asthma. JAMA 1997; 277(11):887–891. [PUBMED], [INFOTRIEVE]
  • Storms W. Double-blind, placebo-controlled study of single doses of chlorofluorocarbon (CFC) and CFC-free cromolyn sodium for exercise-induced bronchoconstriction. Curr Ther Res 1999; 60(12):629–637.
  • National Asthma Education and Prevention Program Expert Panel Report 2. Guidelines for the Diagnosis and Management of Asthma. NHLBI, NIH Publication No. 97-4051, 1997.
  • Bousquet J, van Cauwenberge P, Khaltaev N, Aria Workshop Group, World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108(5 Pt 2):S147–S334. [PUBMED], [INFOTRIEVE], [CSA]
  • Boner A L, Niero E, Grigolini C, Valletta E A, Biancotto R, Gaburro D. Inhibition of exercise-induced asthma by three forms of sodium cromoglycate. Eur J Respir Dis 1985; 66(1):21–24. [PUBMED], [INFOTRIEVE]
  • Tullett W M, Tan K M, Wall R T, Patel K R. Dose-response effect ofsodium cromoglycate pressurized aerosol in exercise induced asthma. 1985; 40(1):41–44.
  • Konig P. The use of cromolyn in the management of hyperreactive airways and exercise. J Allergy Clin Immunol 1984; 73(5 Pt 2):686–689. [PUBMED], [INFOTRIEVE]
  • Bundgaard A, Bach-Mortensen N, Schmidt A. The effect of sodium cromoglycate delivered by Spinhaler and by pressurized aerosol on exercise-induced asthma in children. Clin Allergy 1982; 12(6):601–605. [PUBMED], [INFOTRIEVE]
  • Johnson C E, Belfield P W, Davis S, Cooke N J, Spencer A, Davies J A. Platelet activation during exercise induced asthma: effect of prophylaxis with cromoglycate and salbutamol. Thorax 1986; 41(4):290–294. [PUBMED], [INFOTRIEVE]
  • Moqbel R, Durham S R, Shaw R J, Walsh G M, MacDonald A J, Mackay J A, Carroll M P, Kay A B. Enchancement of leukocyte cytotoxicity after exercise-induced asthma. Am Rev Respir Dis 1986; 133(4):609–613. [PUBMED], [INFOTRIEVE], [CSA]
  • Melo R E, Solé D, Naspitz C K. Comparative efficacy of inhaled furosemide and disodium cromoglycate in the treatment of exercise-induced asthma in children. J Allergy Clin Immunol 1997; 99(2):204–209. [PUBMED], [INFOTRIEVE], [CSA]
  • Lee T H, Nagakura T, Papageorgiou N, Cromwell O, Ikura Y, Kay A B. Mediators in exercise-induced asthma. J Allergy Clin Immunol 1984; 73(5 Pt 2):634–639. [PUBMED], [INFOTRIEVE]
  • Woolley M, Anderson S D, Quigley B M. Duration of protective effect of terbutaline sulfate and cromolyn sodium alone and in combination on exercise-induced asthma.. Chest 1990; 97(1):39–45. [PUBMED], [INFOTRIEVE]
  • Bundgaard A, Buch D, Schmidt A, Bach-Mortensen N. Pretreatment of exercise-induced asthma in children using disodium cromoglycate and fenoterol inhalation powder.. Eur J Respir Dis 1983; 130:36–41.
  • Blumenthal M N, Casale T B, Fink J N, Uryniak T, Casty F E. Evaluation of a non-chlorofluorocarbon formulation of cromolyn sodium (Intal) metered-dose inhaler versus the chlorofluorocarbon formulation in the treatment of adult patients with asthma: a controlled trial. J Allergy Clin Immunol 1998; 101(1):7–13. [PUBMED], [INFOTRIEVE], [CSA]
  • Amayasu H, Nakabayashi M, Akahori K, Ishizaki Y, Shoji T, Nakagawa H, Hasegawa H, Yoshida S. Cromolyn sodium suppresses eosinophil inflammation in patients with aspirin-intolerant asthma. Ann Allergy Asthma Immunol 2001; 87(2):146–150. [PUBMED], [INFOTRIEVE], [CSA]
  • Cockcroft D W. Pharmacologic therapy for asthma: overview and historical perspective. J Clin Pharmacol 1999; 39(3):216–222. [PUBMED], [INFOTRIEVE], [CSA]
  • Global Initiative for Asthma. Global strategy for asthma management and prevention. NHLBI, NIH Publication No. 02-3659, 2002.
  • Juniper E F, Latimer K M, Morris M M, Roberts R S, Hargreave F E. Airway responses to hyperventilation of cold dry air: duration of protection by cromolyn sodium. J Allergy Clin Immunol 1986; 78(3 Pt 1):387–391. [PUBMED], [INFOTRIEVE]
  • Patel K R, Kerr J W. The dose-duration effect of sodium cromoglycate in exercise-induced asthma. Clin Allergy 1984; 14(1):87–91. [PUBMED], [INFOTRIEVE]
  • Brooks C D, Nelson A, Metzler C. Attenuation of protection with repeated cromolyn sodium before exercise challenge in subjects with asthma. J Clin Pharmacol 1986; 26(2):91–96. [PUBMED], [INFOTRIEVE]
  • del Bufalo D, Fasano L, Patalano F, Ruggieri F, Gunella G. Prevention of non-specific bronchial hyperreactivity. Dose-dependent effect of sodium cromoglycate metered dose aerosol. Allergol Immunopathol (Madr) 1988; 16(2):77–80.
  • Furosho K, Nishikawa K, Sasaki S, Akasaka T, Arita M, Edwards A. The combination of nebulized sodium cromoglycate and salbutamol in the treatment of moderate-to-severe asthma in children. Pediatr Allergy Immunol 2002; 13:209–216.
  • van den Toorn L M. Clinical implications of airway inflammation in mild intermittent asthma. Ann Allergy Asthma Immunol 2004; 92(6):589–594. [PUBMED], [INFOTRIEVE]
  • Konig P. The effects of cromolyn sodium and nedocromil sodium in early asthma prevention. J Allergy Clin Immunol 2000; 105(2 Pt 2):S575–S585. [PUBMED], [INFOTRIEVE], [CSA]
  • Harris T AJ, Fuller R W. High dose fluticasone propionate (FP) and its effect on serum cortisol (sCORT) in patients with asthma. Eur Repir J 1996; 9:163S–164S. [CSA]
  • Graham L M. Balancing safety and efficacy in the treatment of pediatric asthma. J Allergy Clin Immunol 2002; 109(6 Pt 2):S560–S566. [PUBMED], [INFOTRIEVE], [CSA]
  • Expert Panel Report. Guidelines for the diagnosis and management of asthma—update on selected topics 2002. J Allergy Clin Immunol 2002; 110(5 Pt 2):S141–S219. [CSA]
  • Mitchell I, Paterson I C, Cameron S J, Grant I WB. Treatment of childhood asthma with sodium cromoglycate and beclomethasone dipropionate aerosol singly and in combination. Br Med J 1976; 2:457–458. [PUBMED], [INFOTRIEVE]
  • Farschou P, Bing J, Edman G, Engel A M. Comparison between sodium cromoglycate (MDI: metered-dose inhaler) and beclomethasone dipropionate (MDI) in treatment of adult patients with mild to moderate bronchial asthma. A double-blind, double dummy randomized, parallel-group study. Allergy 1994; 49(8):659–664. [CSA]
  • Petersen W, Karup-Pedersen F, Friis B, Howitz P, Nielsen F, Strömquist L H. Sodium cromoglycate as a replacement for inhaled corticosteroids in mild-to-moderate childhood asthma. Allergy 1996; 51(12):870–875. [PUBMED], [INFOTRIEVE], [CSA]
  • Shapiro G G, Sharpe M, DeRouen T A, Pierson W E, Furukawa C T, Virant F S, Bierman C W. Cromolyn versus triamcinolone acetonide for youngsters with moderate asthma. J Allergy Clin Immunol 1991; 88(5):742–748. [PUBMED], [INFOTRIEVE], [CSA]
  • Krawiec M E, Wenzel S E. Inhaled nonsteroidal anti-inflammatory medications in the treatment of asthma. Respir Care Clin N Am 1999; 5(4):555–574. [PUBMED], [INFOTRIEVE], [CSA]
  • Rebuck A S. Asthma: non-responsiveness to conventional therapy. Eur J Respir Dis 1986; 147:105–109.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.